Pangea
Founded 2018 · 14 employees on LinkedIn · 1 known investors
Pangea Biomed develops a tumor intelligence platform that uses molecular biology, bioinformatics, and machine learning to predict how a tumor will respond to therapy. It analyzes gene expression and functional genetic interactions to surface precision oncology insights beyond genomic mutations, serving cancer care and drug-matching use cases.
Investors · 1
Frequently asked questions
- What does Pangea do?
- Pangea Biomed develops a tumor intelligence platform that uses molecular biology, bioinformatics, and machine learning to predict how a tumor will respond to therapy. It analyzes gene expression and functional genetic interactions to surface precision oncology insights beyond genomic mutations, serving cancer care and drug-matching use cases.
- Who are Pangea's investors?
- Pangea's investors include NFX.